UF biotech company, Banyan Biomarkers, Inc. has developed the first blood test that can be used by physicians to objectively aid in the evaluation of patients with suspected traumatic brain injury (TBI) or concussions. Banyan is a University of Florida startup and a graduate of UF Innovate | Sid Martin Biotech.
The Banyan Brain Trauma Indicator® (Banyan BTI™) consists of two diagnostic test kits, Banyan UCH-L1® Kit and Banyan GFAP® Kit, which measure two specific protein biomarkers that rapidly appear in the blood after a brain injury.
According to the developers, the Banyan BTI can be used to rule out the need for a head CT scan in patients 18 years of age and older with a suspected TBI.
Learn more about New Diagnostic Blood Test Developed for Concussions.